...
首页> 外文期刊>Anesthesia and Analgesia: Journal of the International Anesthesia Research Society >The Effects of the Toll-Like Receptor 4 Antagonist, Ibudilast, on Sevoflurane's Minimum Alveolar Concentration and the Delayed Remifentanil-Induced Increase in the Minimum Alveolar Concentration in Rats
【24h】

The Effects of the Toll-Like Receptor 4 Antagonist, Ibudilast, on Sevoflurane's Minimum Alveolar Concentration and the Delayed Remifentanil-Induced Increase in the Minimum Alveolar Concentration in Rats

机译:Toll样受体4拮抗剂Ibudilast对七氟醚的最小肺泡浓度和延迟的瑞芬太尼诱导的大鼠最小肺泡浓度增加的影响

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: Ultralow doses of naloxone, an opioid and toll-like receptor 4 antagonist, blocked remifentanil-induced hyperalgesia and the associated increase in the minimum alveolar concentration (MAC), but not tolerance. The aim was to determine the effects of the toll-like receptor 4 antagonist, ibudilast, on the MAC in the rat and how it might prevent the effects of remifentanil.
机译:背景:超低剂量的纳洛酮(一种阿片类和Toll样受体4拮抗剂)可阻止瑞芬太尼引起的痛觉过敏,并随之增加最低肺泡浓度(MAC),但不能耐受。目的是确定Toll样受体4拮抗剂ibudilast对大鼠MAC的作用以及如何预防瑞芬太尼的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号